Microbot Medical (MBOT) Long-Term Deferred Tax (2016 - 2021)

Microbot Medical's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $523.6 million for Q4 2021.

• Quarterly Long-Term Deferred Tax rose 2.21% year-over-year to $523.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $523.6 million (up 2.21% YoY) and the FY2021 annual result came in at $523.6 million, up 2.21% from the prior year.
• Long-Term Deferred Tax was $523.6 million for Q4 2021 at Microbot Medical, up from $512.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $523.6 million in Q4 2021 and bottomed at $495844.0 in Q4 2018.
• A 5-year average of $401.3 million and a median of $490.1 million in 2018 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2018 — Long-Term Deferred Tax slumped 99.9% — and 2019, when it soared 101356.3%.
• Microbot Medical's Long-Term Deferred Tax stood at $488.6 million in 2017, then slumped by 99.9% to $495844.0 in 2018, then surged by 101356.3% to $503.1 million in 2019, then increased by 1.83% to $512.3 million in 2020, then advanced by 2.21% to $523.6 million in 2021.
• Business Quant data shows MBOT's Long-Term Deferred Tax at $523.6 million in Q4 2021, $512.3 million in Q4 2020, and $503.1 million in Q4 2019.